Skip to main content
Psych Capital Plc logo

Psych Capital Plc — Investor Relations & Filings

Ticker · PSY ISIN · GB00BL6CJQ54 LEI · 213800WXCQ1C6GPLHH68 IL Professional, scientific and technical activities
Open in API
Filings indexed 61 across all filing types
Latest filing 2025-08-19 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PSY

About Psych Capital Plc

https://psych.capital/

Shortwave Life Sciences Plc, formerly Psych Capital Plc, is a biopharmaceutical company that originates and develops innovative treatments for mental healthcare. The company's primary clinical program focuses on developing a psilocybin-based therapy for anorexia nervosa, a condition with no currently approved medication. It employs an IP-driven approach, leveraging global partnerships and an experienced leadership team to optimize its drug discovery and development processes. Through its subsidiary, Blossom Analysis, the company also provides a data and insights platform for the psychedelic healthcare industry.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed with the London Stock Exchange via RNS. It explicitly details a change in share ownership (voting rights) for Shortwave Life Sciences Plc, identifying the person subject to the notification obligation (Thomas Grant Nominees Limited) and the percentage of voting rights held. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-08-19 English
Clarification on Strategic Advisor Appointment
Board/Management Information Classification · 99% confidence The document is a regulatory announcement issued via the London Stock Exchange's RNS (Regulatory News Service). It serves as a correction statement regarding a previous announcement about a strategic advisor appointment. Since it is a general regulatory announcement that does not fit into specific categories like M&A, Board changes (as it is a correction of an error rather than a new appointment), or financial reporting, it falls under the RNS fallback category.
2025-08-04 English
£250k Fundraising, New Directors & Review
Share Issue/Capital Change Classification · 99% confidence The document is a multi-faceted regulatory announcement from Shortwave Life Sciences Plc. It covers three primary corporate actions: a capital raise (placing of shares), the appointment of new board members and a strategic advisor, and the subsequent admission of new shares to the Aquis Growth Market. While it contains elements of 'MANG' (Board appointments) and 'SHA' (Share issue), the document is a comprehensive regulatory announcement distributed via RNS that encompasses these events as a single corporate update. Given the primary focus on the capital raise and the resulting share issuance, 'SHA' is the most accurate classification for the core financial event described.
2025-07-29 English
AQSE Only - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an RNS Number (2141O), indicating it is a regulatory filing disseminated via the London Stock Exchange's RNS service. The content details changes in voting rights percentages (crossing thresholds) for a specific shareholder ('Thomas Grant Nominees Limited') in 'Shortwave Life Sciences Plc'. This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-06-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 9862M' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. It uses the standard 'TR-1: Standard form for notification of major holdings' structure, detailing changes in voting rights held by a person subject to notification obligations (Thomas Grant Nominees Limited) and referencing regulatory rules (DTR5.1, DTR5.2.1, DTR5.3.1R). The presence of the RNS distribution service footer confirms it is a regulatory announcement disseminated via the London Stock Exchange's service. This type of filing, reporting changes in significant share ownership, maps directly to the Major Shareholding Notification category.
2025-06-16 English
£40,000 Placing
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from Shortwave Life Sciences Plc regarding a private placement of 32,000,000 new ordinary shares and the issuance of warrants. It details the share price, the purpose of the funding (debt settlement), and the expected admission to the Aquis Growth Market. Because the document describes the issuance of new shares and the resulting change in total voting rights, it falls under the category of share issues and capital changes.
2025-06-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.